Mirena
Payments companies reported to CMS as associated with Mirena. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mirena, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mirena
These are the largest totals companies reported as associated with Mirena. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Benson | Charleston, SC | Anatomic Pathology & Clinical Pathology | $27,473.73 |
| Michelle Hinman | Loveland, CO | Advanced Practice Midwife | $21,364.69 |
| Susan Reed | Seattle, WA | Obstetrics & Gynecology | $17,000.00 |
| Mark Hathaway | Washington, DC | Obstetrics & Gynecology | $10,984.38 |
| Paul Blumenthal | Stanford, CA | Complex Family Planning | $10,157.04 |
| Jenna Benyounes | Chevy Chase, MD | Advanced Practice Midwife | $9,628.17 |
| Anita Nelson | Torrance, CA | Obstetrics & Gynecology | $8,389.14 |
| Jeffrey Peipert | Saint Louis, MO | Gynecology | $8,134.73 |
| Betty Suh-Burgmann | Walnut Creek, CA | Gynecologic Oncology | $7,000.00 |
| Sheila Mody | San Diego, CA | Obstetrics & Gynecology | $6,141.51 |
Prescribed Mirena?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.